Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Skin Laxity: later-stage trial registry
4 of 11 indexed Skin Laxity trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 4 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Skin Laxity: 11 US clinical trials tracked, 4 recruiting.
Skin Laxity is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Ulthera, running 3 of these trials.
Enrollment posture brief
Registry condition skin-laxity
OPEN 4 | RECR 36% | LATE 1 | EARLY 0 | RANK #1577 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (36% recruiting · 11 trials)
Skin Laxity lists 4 open slots (36% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Skin Laxity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Skin Laxity is recruiting below its size-band peers.
4 of 11 indexed trials (36.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Skin Laxity research.
Ulthera accounts for 3 of 11 trials (27.3%). 8 distinct sponsors appear on at least one study for this condition label.
-
Most Skin Laxity trials plan to enrol fewer than 100 people.
Median target enrolment is 35 among the 11 trials that report a genuine target (sentinel values excluded). 8 of those (72.7%) plan for fewer than 100 participants.
-
Skin Laxity research is mostly interventional.
10 interventional and 1 observational studies make up this index (90.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
Sciton
NCT05750901
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
Erchonia Corporation
NCT06941610
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
Galderma R&D
NCT07399028
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
Cytrellis Biosystems
NCT07224880
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
Candela Corporation
NCT06157567
AV-23-001 AVAVA MIRIA Pilot Study
AVAVA
NCT06557434
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
Galderma R&D
NCT06351358
Safety and Efficacy of Sofwave Treatment to Lift Lax Skin
Sofwave Medical
NCT04829227
Feasibility Study: Ulthera Treatment of the Buttocks and Thighs
Ulthera
NCT01708460
Feasibility Study: Lifting and Tightening of the Elbows
Ulthera
NCT01708382
Feasibility Study: Heavy Water Tissue Labeling Protocol
Ulthera
NCT01708525
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Skin Laxity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Skin Laxity trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Skin Laxity page
11 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Skin Laxity trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Ulthera sponsors the most Skin Laxity trials on record, review their full trial history before evaluating a specific study. See Ulthera's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Skin Laxity condition card totals 11 registered trials; most-linked intervention Ulthera System Treatment; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.